Download PDF
Semin Hear 2019; 40(02): 154-161
DOI: 10.1055/s-0039-1684044
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Pediatric Ototoxicity: Current Trends and Management

Brian J. Fligor
1   Tobias and Battite, Inc., Boston, Massachusetts
2   Lantos Technologies, Inc., Wilmington, Massachusetts
3   Osborne College of Audiology, Salus University, Elkins Park, Pennsylvania
› Author Affiliations
Further Information

Publication History

Publication Date:
26 April 2019 (online)

    Permissions and Reprints

Abstract

Medical interventions to combat serious infection or malignancies carry significant morbidities, including ototoxicity. While these lifesaving drugs are often necessary to preserve life, the impact on quality of life for survivors is increasingly concerning for families and healthcare providers. Of primary importance for medical prescribers are appropriately sensitive ototoxicity grading scales and audiological monitoring protocols for surveillance for hearing loss. The intent of grading scales is to help communicate complicated audiological information to non-audiologist healthcare providers (such as oncologists) to help them make good decisions with regards to chemotherapy dosing. Appropriate audiological monitoring helps reduce the time delay between the adventitious onset of hearing loss and the diagnosis and intervention. Finally, pediatric ototoxicity grading and monitoring protocols help ensure timely access to adequate hearing habilitation, verification and validation of the management of permanent medication-induced hearing loss and tinnitus in children.

Keywords

ototoxicity - cisplatin chemotherapy - aminoglycosides
 

  • References

  • 1 Brock PR, Knight KR, Freyer DR. , et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol 2012; 30 (19) 2408-2417
    CrossrefPubMedGoogle Scholar
  • 2 Garinis AC, Kemph A, Tharpe AM, Weitkamp JH, McEvoy C, Steyger PS. Monitoring neonates for ototoxicity. Int J Audiol 2018; 57 (Suppl. 04) S41-S48
    CrossrefPubMedGoogle Scholar
  • 3 Handelsman JA, Nasr SZ, Pitts C, King WM. Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides. Pediatr Pulmonol 2017; 52 (09) 1157-1162
    CrossrefPubMedGoogle Scholar
  • 4 Laurell G, Bagger-Sjöbäck D. Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol 1991; 20 (03) 158-167
    PubMedGoogle Scholar
  • 5 Boothroyd A. Developmental factors in speech recognition. Int J Audiol 1970; 9: 30-38
    PubMedGoogle Scholar
  • 6 Stelmachowicz PG, Pittman AL, Hoover BM, Lewis DE, Moeller MP. The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch Otolaryngol Head Neck Surg 2004; 130 (05) 556-562
    CrossrefPubMedGoogle Scholar
  • 7 Bess FH, Dodd-Murphy J, Parker RA. Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status. Ear Hear 1998; 19 (05) 339-354
    CrossrefPubMedGoogle Scholar
  • 8 Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML. ; Children's Oncology Group. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group. Pediatrics 2007; 120 (05) e1229-e1236
    CrossrefPubMedGoogle Scholar
  • 9 Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 1991; 19 (04) 295-300
    CrossrefPubMedGoogle Scholar
  • 10 National Cancer Institute Common Terminology Criteria for Adverse Events v5.0. Cancer Therapy Evaluation Program. Available at: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5.0.xlsx . Published November 27, 2017 , accessed November 14, 2018
    PubMed
  • 11 Minasian LM, Frazier AL, Sung L. , et al. Prevention of cisplatin-induced hearing loss in children: informing the design of future clinical trials. Cancer Med 2018; 7: 2951-2959
    CrossrefPubMedGoogle Scholar
  • 12 Jiang M, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: a review. Front Cell Neurosci 2017; 11: 308
    CrossrefPubMedGoogle Scholar
  • 13 Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: an overview. Cold Spring Harb Perspect Med 2016; 6 (06) a027029
    CrossrefPubMedGoogle Scholar
  • 14 Shah SU, Anjum S, Littler WA. Use of diuretics in cardiovascular diseases: (1) heart failure. Postgrad Med J 2004; 80 (942) 201-205
    CrossrefPubMedGoogle Scholar
  • 15 Li H, Steyger PS. Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics. Noise Health 2009; 11 (42) 26-32
    CrossrefPubMedGoogle Scholar
  • 16 American Academy of Audiology. Pediatric amplification: clinical practice guidelines. Published June 2013. Available at: https://www.audiology.org/sites/default/files/publications/PediatricAmplificationGuidelines.pdf . Accessed November 21, 2018
    PubMedGoogle Scholar
  • 17 Sininger YS, Grimes A, Christensen E. Auditory development in early amplified children: factors influencing auditory-based communication outcomes in children with hearing loss. Ear Hear 2010; 31 (02) 166-185
    CrossrefPubMedGoogle Scholar
  • 18 Campbell KC, Martin SM, Meech RP, Hargrove TL, Verhulst SJ, Fox DJ. D-methionine (D-met) significantly reduces kanamycin-induced ototoxicity in pigmented guinea pigs. Int J Audiol 2016; 55 (05) 273-278
    CrossrefPubMedGoogle Scholar
  • 19 Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics 2005; 115 (06) 1519-1528
    CrossrefPubMedGoogle Scholar
  • 20 Knight KR, Chen L, Freyer D. , et al. Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the Children's Oncology Group. J Clin Oncol 2017; 35 (04) 440-445
    PubMedGoogle Scholar
  • 21 Dille MF, Ellingson RM, McMillan GP, Konrad-Martin D. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring. J Am Acad Audiol 2013; 24 (09) 769-781
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Rance G, Roper R, Symons L. , et al. Hearing threshold estimation in infants using auditory steady-state responses. J Am Acad Audiol 2005; 16 (05) 291-300
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Vander Werff KR, Prieve BA, Georgantas LM. Infant air and bone conduction tone burst auditory brain stem responses for classification of hearing loss and the relationship to behavioral thresholds. Ear Hear 2009; 30 (03) 350-368
    CrossrefPubMedGoogle Scholar
  • 24 Knight KR, Kraemer DF, Winter C, Neuwelt EA. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 2007; 25 (10) 1190-1195
    CrossrefPubMedGoogle Scholar
  • 25 Dille MF, McMillan GP, Reavis KM, Jacobs P, Fausti SA, Konrad-Martin D. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model. J Acoust Soc Am 2010; 128 (03) 1163-1174
    CrossrefPubMedGoogle Scholar
  • 26 Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D. Development and validation of a cisplatin dose-ototoxicity model. J Am Acad Audiol 2012; 23 (07) 510-521
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Bhatt JM, Lin HW, Bhattacharyya N. Tinnitus epidemiology: prevalence, severity, exposures and treatment patterns in The United States. JAMA Otolaryngol Head Neck Surg 2016; 142: 959-965
    CrossrefPubMedGoogle Scholar
  • 28 Hall DA, Fackrell K, Li AB. , et al. A narrative synthesis of research evidence for tinnitus-related complaints as reported by patients and their significant others. Health Qual Life Outcomes 2018; 16 (01) 61
    CrossrefPubMedGoogle Scholar
  • 29 Meikle MB, Henry JA, Griest SE. , et al. The tinnitus functional index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear 2012; 33 (02) 153-176
    CrossrefPubMedGoogle Scholar
  • 30 Fligor BJ. Audiological evaluation and management of teenagers with tinnitus. ENT Audiol News 2017; 25: 93-94
    PubMedGoogle Scholar